Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer.
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer. Oncotarget. 2018 Apr 10; 9(27):18985-18996.
View in:
PubMed
authors with profiles
Yusuke Nakamura